Quest Diagnostics (DGX) Leases (2019 - 2025)
Historic Leases for Quest Diagnostics (DGX) over the last 10 years, with Q3 2025 value amounting to $649.0 million.
- Quest Diagnostics' Leases fell 181.54% to $649.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $649.0 million, marking a year-over-year decrease of 181.54%. This contributed to the annual value of $651.0 million for FY2024, which is 813.95% up from last year.
- Latest data reveals that Quest Diagnostics reported Leases of $649.0 million as of Q3 2025, which was down 181.54% from $655.0 million recorded in Q2 2025.
- Quest Diagnostics' Leases' 5-year high stood at $661.0 million during Q3 2024, with a 5-year trough of $579.0 million in Q1 2024.
- For the 5-year period, Quest Diagnostics' Leases averaged around $613.5 million, with its median value being $603.0 million (2024).
- As far as peak fluctuations go, Quest Diagnostics' Leases surged by 1718.75% in 2021, and later plummeted by 500.0% in 2023.
- Quest Diagnostics' Leases (Quarter) stood at $597.0 million in 2021, then fell by 2.01% to $585.0 million in 2022, then rose by 2.91% to $602.0 million in 2023, then rose by 8.14% to $651.0 million in 2024, then decreased by 0.31% to $649.0 million in 2025.
- Its Leases stands at $649.0 million for Q3 2025, versus $655.0 million for Q2 2025 and $656.0 million for Q1 2025.